178 related articles for article (PubMed ID: 8438583)
1. The block to HIV-1 envelope glycoprotein-mediated membrane fusion in animal cells expressing human CD4 can be overcome by a human cell component(s).
Broder CC; Dimitrov DS; Blumenthal R; Berger EA
Virology; 1993 Mar; 193(1):483-91. PubMed ID: 8438583
[TBL] [Abstract][Full Text] [Related]
2. Heat-resistant factors in human erythrocyte membranes mediate CD4-dependent fusion with cells expressing HIV-1 envelope glycoproteins.
Puri A; Morris SJ; Jones P; Ryan M; Blumenthal R
Virology; 1996 May; 219(1):262-7. PubMed ID: 8623537
[TBL] [Abstract][Full Text] [Related]
3. Mapping of the human immunodeficiency virus type 2 envelope glycoprotein CD4 binding region and fusion domain with truncated proteins expressed by recombinant vaccinia viruses.
Otteken A; Voss G; Hunsmann G
Virology; 1993 May; 194(1):37-43. PubMed ID: 8480426
[TBL] [Abstract][Full Text] [Related]
4. Coexpression of a nonsyncytium inducer HIV-1 glycoprotein inhibits syncytium formation by another HIV-1 Env protein.
Li YY; O'Donnell MA; Perez LG
Virology; 1996 Jan; 215(2):197-202. PubMed ID: 8560767
[TBL] [Abstract][Full Text] [Related]
5. Chemically induced CD4 mutants of a human T cell line. Evidence for dissociation between binding of HIV I envelope and susceptibility to HIV I infection and syncytia formation.
Hillman K; Shapira-Nahor O; Gruber MF; Hooley J; Manischewitz J; Seeman R; Vujcic L; Geyer SJ; Golding H
J Immunol; 1990 Mar; 144(6):2131-9. PubMed ID: 1690235
[TBL] [Abstract][Full Text] [Related]
6. Specific interaction of CXCR4 with CD4 and CD8alpha: functional analysis of the CD4/CXCR4 interaction in the context of HIV-1 envelope glycoprotein-mediated membrane fusion.
Basmaciogullari S; Pacheco B; Bour S; Sodroski J
Virology; 2006 Sep; 353(1):52-67. PubMed ID: 16808956
[TBL] [Abstract][Full Text] [Related]
7. An anti-human immunodeficiency virus multiple antigen peptide encompassing the cleavage region of the env precursor interferes with membrane fusion at a post-CD4 binding step.
Barbouche R; Decroly E; Kieny MP; Fenouillet E
Virology; 2000 Jul; 273(1):169-77. PubMed ID: 10891419
[TBL] [Abstract][Full Text] [Related]
8. Alpha-complementation assay for HIV envelope glycoprotein-mediated fusion.
Holland AU; Munk C; Lucero GR; Nguyen LD; Landau NR
Virology; 2004 Feb; 319(2):343-52. PubMed ID: 14980494
[TBL] [Abstract][Full Text] [Related]
9. HIV envelope glycoprotein-induced cell killing by apoptosis is enhanced with increased expression of CD26 in CD4+ T cells.
Jacotot E; Callebaut C; Blanco J; Rivière Y; Krust B; Hovanessian AG
Virology; 1996 Sep; 223(2):318-30. PubMed ID: 8806567
[TBL] [Abstract][Full Text] [Related]
10. The role of cholesterol and sphingolipids in chemokine receptor function and HIV-1 envelope glycoprotein-mediated fusion.
Ablan S; Rawat SS; Viard M; Wang JM; Puri A; Blumenthal R
Virol J; 2006 Dec; 3():104. PubMed ID: 17187670
[TBL] [Abstract][Full Text] [Related]
11. Cell fusion activity of the simian immunodeficiency virus envelope protein is modulated by the intracytoplasmic domain.
Ritter GD; Mulligan MJ; Lydy SL; Compans RW
Virology; 1993 Nov; 197(1):255-64. PubMed ID: 8212561
[TBL] [Abstract][Full Text] [Related]
12. A retroviral vector capable of targeted gene transfer into cells expressing HIV envelope glycoprotein.
Suzuki S; Shimada T
Biochem Biophys Res Commun; 2000 May; 271(3):672-6. PubMed ID: 10814520
[TBL] [Abstract][Full Text] [Related]
13. Interactions of CCR5 and CXCR4 with CD4 and gp120 in human blood monocyte-derived dendritic cells.
Xiao X; Kinter A; Broder CC; Dimitrov DS
Exp Mol Pathol; 2000 Jun; 68(3):133-8. PubMed ID: 10816381
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effects of small-molecule CCR5 antagonists on human immunodeficiency virus type 1 envelope-mediated membrane fusion and viral replication.
Takashima K; Miyake H; Furuta RA; Fujisawa JI; Iizawa Y; Kanzaki N; Shiraishi M; Okonogi K; Baba M
Antimicrob Agents Chemother; 2001 Dec; 45(12):3538-43. PubMed ID: 11709336
[TBL] [Abstract][Full Text] [Related]
15. The human immunodeficiency virus type 1 Vpu protein tethered to the CD4 extracellular domain is localized to the plasma membrane and is biologically active in the secretory pathway of mammalian cells: implications for the mechanisms of Vpu function.
Raja NU; Jabbar MA
Virology; 1996 Jun; 220(1):141-51. PubMed ID: 8659106
[TBL] [Abstract][Full Text] [Related]
16. Functional expression of CD4, CXCR4, and CCR5 in glycosphingolipid-deficient mouse melanoma GM95 cells and susceptibility to HIV-1 envelope glycoprotein-triggered membrane fusion.
Rawat SS; Eaton J; Gallo SA; Martin TD; Ablan S; Ratnayake S; Viard M; KewalRamani VN; Wang JM; Blumenthal R; Puri A
Virology; 2004 Jan; 318(1):55-65. PubMed ID: 14972535
[TBL] [Abstract][Full Text] [Related]
17. Human immunodeficiency virus envelope glycoprotein/CD4-mediated fusion of nonprimate cells with human cells.
Ashorn PA; Berger EA; Moss B
J Virol; 1990 May; 64(5):2149-56. PubMed ID: 2109100
[TBL] [Abstract][Full Text] [Related]
18. Truncation of the human immunodeficiency virus-type-2 envelope glycoprotein allows efficient pseudotyping of murine leukemia virus retroviral vector particles.
Höhne M; Thaler S; Dudda JC; Groner B; Schnierle BS
Virology; 1999 Aug; 261(1):70-8. PubMed ID: 10441556
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 coreceptor activity of CCR5 and its inhibition by chemokines: independence from G protein signaling and importance of coreceptor downmodulation.
Alkhatib G; Locati M; Kennedy PE; Murphy PM; Berger EA
Virology; 1997 Aug; 234(2):340-8. PubMed ID: 9268166
[TBL] [Abstract][Full Text] [Related]
20. Biological properties of recombinant HIV envelope synthesized in CHO glycosylation-mutant cell lines.
Fenouillet E; Miquelis R; Drillien R
Virology; 1996 Apr; 218(1):224-31. PubMed ID: 8615025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
